Are you Dr. Restrepo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 98 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1901 S 2nd St
McAllen, TX 78503Phone+1 956-687-5150Fax+1 956-687-9546
Summary
- Dr. Alvaro Restrepo, MD is an oncologist in McAllen, Texas. He is currently licensed to practice medicine in Texas and Florida. He is affiliated with Rio Grande Regional Hospital, Doctor's Hospital at Renaissance, and Mission Regional Medical Center.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1997- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991 - 1993
Institute of Health Sciences Medellin Faculty of MedicineClass of 1987
Certifications & Licensure
FL State Medical License 1992 - 2027
TX State Medical License 2001 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer Start of enrollment: 2019 Jun 11
Publications & Presentations
PubMed
- Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens.Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu
Breast Cancer Research and Treatment. 2024-05-01 - 16 citationsEflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.Lee S. Schwartzberg, Gajanan Bhat, Julio Antonio Peguero, Richy Agajanian, Jayaram S. Bharadwaj
The Oncologist. 2020-08-01 - 4 citationsKaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas averageWendy Innis-Whitehouse, Xiaohui Wang, Nicolas Restrepo, Carlos Salas, Katia Moreno
Cancer Treatment and Research Communications. 2018-01-01
Press Mentions
Two-Time Breast Cancer Survivor Shares Importance of MammogramsOctober 28th, 2021- Convince Me: Why Should I Participate in a Clinical Trial?June 12th, 2018
